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Abstract 
The effect of aluminium, A13+ (10 mg/kg body weight/day i.p.) for a period of 4 weeks was examined on the calcium homeostatic 
mechanisms in rat central nervous ystem. Incubation of synaptosomes prepared from rat brain, with aluminium in vitro had a detrimental 
effect on the activity of Ca 2+ ATPase which could be reversed completely on exogenous addition of desferrioxamine (10 #M) and 
partially with glutathione (1 raM). In vivo administration also revealed a similar observation. A marked increase in the levels of 
intracellular calcium was observed after aluminium treatment. Concomitant to the increased levels of intracellular calcium, there was an 
increase in the levels of lipid peroxidation and a consequent decrease in fluidity of synaptic plasma membranes. In addition, aluminium 
also had an inhibitory effect on the depolarization-induced alcium uptake which was found to be of a competitive type. The biological 
activity of calcium regulatory proteins calmodulin and protein kinase C was considerably affected by aluminium. The results suggest that 
aluminium exerts its toxic effects by modification of the intracellular calcium messenger system with detrimental consequences on 
neuronal functioning. 
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I. Introduction 
A steadily increasing amount of evidence reported in 
recent years has confirmed the fact that aluminium (A13+ ) 
can have severe neurotoxic effects [1]. Aluminium has 
been detected in both senile plaques [2] and neurofibrillary 
tangle bearing neurons [3] of patients with neurodegenera- 
tive diseases, particularly the Alzheimer's disease. It has 
also been shown that in some patients undergoing long-term 
hemodialysis, the accumulation of large amounts of A13+ 
is directly responsible for the development of dialysis 
encephalopathy. Despite intense interest in the etiology of 
these neurological syndromes, there are very few reports 
regarding the effects of AI 3+ on the metabolism of normal 
humans and animals. 
The molecular mechanisms by which AI 3+ exerts its 
neurotoxic effects remain unknown. However, several facts 
suggest hat AI 3+ can interact with Ca 2+ binding sites and 
disrupt intraneuronal Ca 2+ homeostasis, since in most of 
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the neurodegenerative diseases, in which A13+ has been 
implicated, a Ca 2+ excess along with A13+, has been 
reported [4]. High concentrations of A13+ and Ca 2+ in the 
CNS tissue play a critical role in neurodegeneration, pro- 
ducing neurofibrillary tangles and inducing cell death. 
Intracellular Ca 2 + ions play an important role as second 
messengers that mediate the effects of a variety of extra- 
cellular signals. There is hardly any cellular function that 
is not affected directly or indirectly by the ubiquitous 
second messenger Ca 2+ [5]. Homeostatic mechanisms 
maintain [Ca2+]i at low concentrations and are a pre- 
requisite for normal neuronal functioning. Alterations in 
this [Ca2+]i homeostasis can lead to nervous system dys- 
function, as the neuronal functions involved in long-term 
potentiation like memory and learning are thought to be 
linked to Ca 2 +-triggered intracellular events [6]. 
In view of the altered state of Ca 2 + metabolism during 
the course of neurodegenerative diseases and the fact that 
it has a role to play in altered neurological functions, a 
detailed investigation on brain Ca 2+ homeostasis are im- 
perative. Therefore, in the present study the effect of A13+ 
on Ca 2+ homeostatic mechanisms, viz., Ca 2+ effluxing 
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and influxing systems and eventually on the levels of 
[Ca2+] i and the activity of calcium regulatory proteins, 
have been investigated. 
2. Materials and methods 
Calmodulin, activator-deficient cAMP phospho- 
diesterase (PDE), cyclic AMP (cAMP), 5'-nucleotidase 
(Snake Venom), EGTA, adenosine triphosphate, Dowex 
1 × 2 (200-400 mesh) anion exchanger were obtained 
from Sigma Chemicals, St. Louis, MO, USA. Fura 2 /AM 
was obtained from Molecular Probes, Inc., Eugene, USA. 
Desferrioxamine (DES) was obtained from Ciba Geigy, 
Basle, Switzerland. [2, 8-3H]Adenosine 3'-5'-cyclic 
monophosphate (spec. act. 41.7 Ci/mmol) was obtained 
from Amersham Inc., UK and 45Ca2+ (Spec. act. 105 
mCi/mmol) from Bhabha Atomic Research Centre, Bom- 
bay, India. All other chemicals used were highest grade 
commercial products. 
2.1. Animals and treatment 
Male albino rats (wistar strain) weighing between 100- 
130 g were used throughout the course of study. Animals 
were housed in poly-propylene cages under hygienic con- 
ditions, fed standard rat pellet diet (Hindustan Lever Ltd., 
India) and water ad libitum. For in vivo studies, animals 
were divided into two groups of 8 animals each, which 
received either aluminium (10 mg/kg body weight/day) 
as aluminium lactate, for a period of 4 weeks (treated 
group), or an equal volume of 0.9% NaC1 (control group), 
intraperitoneally. After the completion of the treatment, the 
animals were fasted overnight and then killed by decapita- 
tion. The brains were removed, rinsed in ice-cold normal 
saline and dissected into the different brain regions, viz., 
cerebral cortex, hippocampus, and corpus striatum, accord- 
ing to the guidelines of Glowinski and Iversen [7]. 
2.2. Subcellular f actions 
Synaptosomal plasma membranes (SPMs) were pre- 
pared from different regions of rat brain according to the 
method of Jones and Matus [8]. Briefly, the crude mito- 
chondrial fractions were suspended in hypotonic buffer (5 
mM Tris-HC1, pH 8.0) at 0°C for 30 rain, followed by 
homogenization. The lysate was made 34% (w/v)  with 
sucrose by the addition of an appropriate volume of 48% 
(w/v)  sucrose. An upper phase of 28.5% (w/v)  sucrose 
was layered over the sample phase and a small volume of 
10% (w/v)  sucrose layered over the upper phase. The 
density gradient was centrifuged at 60000× g for 110 
min. The SPMs were collected from interface between the 
layers 10% and 28.5% and resuspended in 40 mM Tris- 
HCI, pH 7.4. 
Synaptosomes were prepared on a discontinuous u- 
crose gradient according to the procedure of Gray and 
Whittaker [9]. Briefly, the crude mitochondrial pellet was 
suspended in 0.32 M sucrose in 20 mM Tris-HC1 (pH 7.4) 
and the suspension layered on a stepwise density gradient 
consisting of layers of 0.8 M, 1.0 M and 1.2 M sucrose. 
After centrifugation at 80000 X g for 2 h, the interface 
over 1.0 M sucrose was recovered and constituted the 
synaptosomal fraction (synaptosomes). Synaptosomes were 
suspended in physiological buffer of the following compo- 
sition, 20 mM Tris-HC1 (pH 7.4), 130 mM NaC1, 4.9 mM 
KC1, 1.2 mM CaC12, 1.2 mM MgCI 2 and 11 mM glucose. 
2.3. Analytical methods 
Synaptosomal K +-stimulated 45Ca2 + uptake was mea- 
sured in unstimulated (low K + medium = 4.9 mmol KCI) 
and stimulated (high K + medium= 106 mmol KC1) 
synaptosomes by the method of Edelfors and Ravn-Jonsen 
[10]. Uptake was terminated with 3 ml of stop solution (1.8 
mM LaC13 and 1 mM EGTA in 0.15 M NaCI, pH 7.4) 
followed by filtration of the sample through 0.45 /xm 
nitrocellulose filters (Whatman, UK). Non-specific binding 
was determined by measuring the uptake at zero time. The 
net potassium induced 45Ca2+ uptake (AK) was expressed 
as the difference in nmol of 45Ca2+ taken up per mg of 
protein between 45Ca2+ uptake across the synaptosomal 
membrane under unstimulated (low K +) and stimulated 
(high K +) conditions. 
Ca 2+ ATPase was assayed in the synaptic plasma 
membranes by the method of Desaiah et al. [11]. The 
reaction mixture (1.5 ml) contained 40 mM Tris-HCl (pH 
7.5), 5 mM MgCI 2, 0.05 mM CaC12 and 2.5 mM ATP. 
The Mg2+-ATPase activity was determined in the presence 
of 1 mM EGTA and this was subtracted from the total 
activity in order to obtain the net Ca2+ATPase activity. 
The inorganic phosphate released by the action of ATPase 
was estimated by the method of Fiske and SubbaRow [12]. 
lntrasynaptosomal free Ca 2+ was determined in 
synaptosomes with the calcium-sensitive indicator dye fura 
2/AM according to the method of Adamson et al. [13]. 
Briefly, synaptosomes (inphysiological buffer) were loaded 
with 1 /~M Fura-2/AM at 37°C for 1 h. The excess Fura 
2/AM was removed by centrifugation. The fluorescence 
(F) at 340 to 380 nm excitation and 510 nm emission was 
measured and [Ca2+] i was calculated according to the 
formula. 
[ Caz+ ]i = ( F - Fmin)/( Fma x - F)  X K d 
The K d for Fura-free acid is 225 mM [14]. Maximal 
fluorescence was measured after lysis of synaptosomes 
with SDS and minimal fluorescence (Fmi .) was measured 
in the presence of 5 mM EGTA. 
Lipid peroxidation (LPx) was ascertained by measuring 
malondialdehyde, an index of lipid peroxidation, according 
to the method of Wills [15]. The malondialdehyde in the 
samples was reacted with thiobarbituric acid (TBA) and 
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the chromophore was read at 532 nm. The results were 
expressed as nmoles of MDA per mg of protein using the 
molar extinction co-efficient of the MDA-TBA chro- 
mophore (1.56 × 105). 
Membranefiuidity of SPMs was assessed by the method 
of Shinitzky and lnbar [16], using the fluorescent probe 
diphenyl-l,3,5-hexatriene (DPH). Briefly, the membranes 
(in 0.1 M Tris-HC1, pH 7.0) were incubated with 10 /zM 
DPH. Mixture was incubated at 37°C for 1 h. and cen- 
trifuged at 10000 × g for 15 min. Pellet obtained was 
washed with and suspended in PBS. Fluorescence was 
measured on a spectrofluorimeter (Kontron SFM 25) at 
445/350 nm emission and excitation wavelengths respec- 
tively. 
Calmodulin (CAM) was assayed in the heat-treated tis- 
sue extract by its ability to stimulate activator-deficient 
cAMP phosphodiesterase activity according to the method 
of Wallace et al. [ 17]. 
Protein kinase C was assayed according to the method 
of Kikkawa et al. [18], wherein the transfer of 32p from 
(3/_ 32 p) ATP to lysine rich histone in the presence of Ca 2+ 
and phosphatidyl serine, was measured with or without 
diolein. Basal activity (due to other kinases), measured by 
omission of Ca 2 ~ and phosphatidyl serine and addition of 
excess of EGTA, was deducted from the total enzyme 
activity. 
Aluminium analysis was carried out in the tissues by 
the wet acid digestion method of Zumkley et al. [19]. The 
samples were digested in the acid mixture of 90% HNQ,  
70% HCIQ and 10 N H2SO 4 in the ratio 2:2:1. The 
residue obtained was reconstituted in 0.1 M HCI. Alu- 
minium was estimated on a Direct Current Plasma Emis- 
sion Spectrophotometer (Spectraspan, V. Beckman). 
Proteins in the samples were quantitated by the method 
of Lowry et al. [20]. 
2.4. Statistical analysis 
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Values in the tables and figures are means + S.D. Com- 
parison between two means have been made using Stu- 
dent's t-test, P-values higher than 0.05 have been consid- 
ered insignificant. 
3. Results 
Ca 2+ ATPase, a CaM-regulated membrane-bound en- 
zyme is responsible for expelling calcium from the neu- 
rons and thus maintaining low intracellular calcium levels. 
Varying concentrations of aluminium (0-100 /zM) caused 
a dose-dependent decrease in the activity of the enzyme, 
with the 50% inhibitory concentration (ICs0) for alu- 
minium being calculated to be approx. 10 /zM (Fig. 1). 
Exogenously added (10 /zM) desferrioxamine (DES), 
an AI 3+ and Fe 3+ chelator was able to almost completely 
restore the enzyme activity. However, addition of exoge- 
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Fig. I. Dose response curve of Ca 2÷ ATPase activity against aluminium 
concentration. The Ca 2 + ATPasc was assayed in the presence of alu- 
minium (0-100 /zM) in SPMs prepared from rat brain. Values are 
mean_+ S.D. of tour sets of experiments. 
nous glutathione (1 mM) could only partially restore the 
enzyme activity (Fig. 2). Ca 2+ ATPase activity, when 
measured, following in vivo aluminium exposure (10 
mg/kg  body weight, for a period of four weeks) revealed 
a significant decrease in the treated group as compared to 
the control group (Fig. 3). Maximum inhibition was ob- 
served in corpus striatum (56.44%), followed by hip- 
pocampus (52.52%) and cerebral cortex (50%). 
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Fig. 2. Reversal of Ca 2+ ATPase activity by exogenous addition of 
desferrioxamine and glutathione. The Ca 2+ ATPase activity inhibited by 
IC50 concentrations of aluminium was determined in the presence of 
desferrioxamine (I 0/.LM) and glutathione ( 1 mM). Values are mean _+ S.D. 
of four sets of experiments ~~ * P < 0.001, statistically significant from 
that in the absence of aluminium, +++ P < 0.001, statistically significant 
from that in the presence of aluminium. 
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Fig. 3. Effect of  in vivo aluminium exposure on the Ca 2÷ ATPase 
activity in SPMs. Values are mean +_ S.D. of 8 an imals /group.  * * * P < 
0.001, statistically signif icant from control group. 
As evident from the above data, A13+ significantly 
alters Ca 2+ handling in the nerve terminals in terms of 
Ca -?+ efflux which may have dramatic onsequences on 
the intrasynaptosomal C  2 + concentration ([Ca 2 + ]i), a sen- 
sitive indicator of neurotoxicity. Our results presented in 
Table 1, revealed a nearly 2-fold increase in the levels of 
resting [Ca2+]i in the treated rats as compared to the 
control animals. Maximum increase was observed in the 
cerebral cortex > hippocampus > corpus striatum, in that 
order, suggesting thereby that A13÷ exposure alters the 
ability of nerve terminals to expel Ca 2+, leading to an 
elevation of intrasynaptosomal C  2 ÷ levels. 
One of the major consequences of increased [Ca2+]i 
levels is the enhanced production of free radicals, which 
can have detrimental effects on the integrity of cellular 
membranes in terms of lipid peroxidation. Therefore, the 
effect of AI 3+ exposure on the levels of malondialdehyde, 
an index of lipid peroxidation, was investigated. In vivo 
A13÷ exposure resulted in a significant accentuation i  the 
levels of LPx (Table 1) and the maximum increase was 
observed in the cerebral cortex (1.66-fold), followed by 
hippocampus (1.41-fold) and corpus striatum (l.21-fold). 
The consequence of enhanced peroxidation is the loss of 
membrane phospholipids which is eventually responsible 
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Fig. 4. Effect of  in vitro alurniuium exposure on 45Ca2+ uptake in 
synaptosomes. 45Ca2+ uptake was measured in unstimulated (O)  and 
stimulated (0 )  synaptosomes fol lowing incubation with aluminium (0 -  
1000 /zM) for 30 min. Inset depicts the net uptake (AK).  Values are 
mean +__ S.D. of  four sets of  experiments. 
for alterations in membrane fluidity. Therefore, the fluidity 
of synaptic plasma membranes was assessed using the 
fluorescent probe DPH. The results presented in Table 1 
indicate that the fluorescence polarisation, which is in- 
versely proportional to membrane fluidity, increased fol- 
lowing A13+ exposure. 
In order to evaluate the effect of AI 3+ on voltage-oper- 
ated calcium channels (VOCC), which play a pivotal role 
in coupling electrical activity to neurotransmission, the 
Ca 2÷ uptake under stimulated (high K + medium) and 
unstimulated (low K ÷ medium) conditions was measured 
in the synaptosomes. Fig. 4 shows the effect of varying 
concentrations of A13+ (0-1000 /~M) on 45Ca2+ influx. 
The net K ÷ induced Ca z÷ influx, AK, (inset) was inhib- 
Table 1 
Effect of a luminium exposure on the levels of  [Ca 2+ ]i, lipid peroxidation and on the membrane fluidity in different regions of  rat brain 
[ Ca2+ ]i (nM) Lipid peroxidation 
(nmol MDA/mg protein) 
Fluorescent polarisation (P) 
Control Al-treated Control Al-treated Control Al-treated 
Cerebral cortex 104.03 + 13.83 298.94 5- 63.34 * * * 5.09 5:0.26 8.46 + 0.51 * * * 0.29 + 0.01 0.34 -I- 0,01 * * * 
H ippocampus 157.36 -t-_ 18.21 300.02 ± 25.82 * * * 5.07 + 0.26 7.16 +_ 0.23 * * * 0.26 ztz 0.05 0.35 + 0.02 * * * 
Corpus striatum 178.28 ___ 7.17 240.37 + 18.18 * * * 5.20 + 0.58 6.33 + 0.40 * * * 0.240 + 0.05 0.34 5- 0.01 * * * 
Rats were exposed to aluminium (10 mg/kg  body weight, i.p.) for four weeks. 
Values are mean 5: S.D. of  8 an imals /group .  
* * * P < 0.001, statistically significant from control group. 
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Fig. 5. Effect of in vivo aluminium exposure on the depolarization 
induced calcium influx in synaptosomes. 45Ca2+ uptake was measured 
after 1 min in unstimulated (U) and stimulated (S) synaptosomes. Inset 
indicates the values of /IK (net K+-induced Ca 2+ influx). Values are 
mean 5- S.D. of 8 animals/group * P < 0.05, * ~ * P < 0.001, statisti- 
cally significant from control group. 
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Fig. 7. Effect of in vivo aluminium exposure on the activity of calmod- 
ulin in different regions of rat brain. Calmodulin was assayed in the 
heat-treated supernatant in terms of its ability to stimulate cAMP 
phosphodiesterase, Values are mean 5- S.D. of 8 animals/group ~ * * P < 
0.001, statistically significant from control group. 
ited at all the concentrations of A13÷ with IC50 of A13÷ 
for the net uptake being at 50 /zM concentration of A13+. 
At higher concentrations, the uptake was completely abol- 
ished. 
In order to determine the type of inhibition of 45Ca2÷ 
uptake by A13+, a double reciprocal plot of 45Ca2+ uptake 
vs external Ca 2÷ concentrations was plotted in the pres- 
ence (50 /zM) and absence of AI 3+. The results indicate 
that there was only a slight change in the values of Jc ~ax 
(maximal Ca 2÷ uptake) in the presence of A13+ (7.14) as 
compared to that in its absence (9,09) in terms of nM 
45Ca2- uptake/min/mg protein, whereas the values of 
Kca (concentration of external Ca 2÷ at which Jca = 1/2 
jMax in mM extracellular calcium), increased in the pres- Ca 
ence of A13+ (3.22), as compared to those in its absence 
(1.89), indicating the inhibition to be of a mixed type (i.e., 
a combination of competitive and non-competitive type). 
In vivo exposure to aluminium for a period of four weeks 
on the Ca 2 ÷ uptake via VOCC, as demonstrated in Fig. 5, 
revealed a significant decrease in 45Ca2+ uptake in 
synaptosomes following incubation with ~SCa for 1 min in 
both polarized and depolarized media. The net uptake 
(inset), i.e., AK, was also inhibited. The maximum inhibi- 
tion was observed in corpus striatum (84.79%) followed by 
cerebral cortex (58.41%) and hippocampus (45.94%). 
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Fig, 6. Effect of in vitro aluminium on the biological activity of calmod- 
ulin. Aluminium ions (0-100 /zM) were incubated with calmodulin- 
stimulated (0 )  and basal (C)) cAMP phosphodiesterase for 30 min. 
Values are mean 5- S.D. of four sets of experiments. 
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Fig. 8. Effect of in vitro aluminium on the activity of protein kinase C, 
The activity of PKC was assayed by its ability to transfer 32 p from ATP 
to histone in the presence of aluminium (0-100 /xM). Values are 
mean 5- S.D. of four sets of experiments. 
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Fig. 9. Effect of in vivo aluminium exposure on calcium regulatory 
protein, PKC. Values are mean _+ S.D, of 8 animals/group. * P < 0.05, 
• ~ * P < 0.001 statistically significant from control group. 
The activities of calmodulin and protein kinase C were 
also investigated following A13+ exposure. In vitro incuba- 
tion of AI 3+ (0- I000 /zM) with CaM had a detrimental 
effect on the biological activity of the protein. However, 
basal cAMP phosphodiesterase was only slightly affected 
by A13+ ions (Fig. 6). In vivo administration of AI 3+ also 
inhibited the CaM activity with the maximum decrease 
being in hippocampus (36.56%) followed by cerebral cor- 
tex (31.76%) and corpus striatum (22.49%) (Fig. 7). 
Incubation with varying concentrations of aluminium 
(0-100 /xM) inhibited the activity of PKC at all the 
concentrations of AI 3+ (Fig. 8). In vivo A13+ exposure 
(Fig. 9) further substantiated this result, where the maxi- 
mum inhibition was observed in the cerebral cortex 
(47.73%) and hippocampus (45.95%) followed by corpus 
striatum (38.74%). 
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Fig. 10. Distribution of aluminium in different regions of rat brain. 
Values are mean + S.D. of 8 animals/group. * ** P < 0.001, statistically 
significant from control group. 
The distribution of A13÷ revealed accumulation in all 
the regions, maximum being in the hippocampus followed 
by corpus striatum > cerebral cortex > cerebellum in that 
order (Fig. 10). 
4. Discussion 
The role of calcium and its homeostatic mechanisms as 
intracellular regulators of many physiological processes is 
an important area of study in different fields of biology. 
The results from the present study demonstrated that AI 3* 
affects Ca 2 * homeostatic mechanisms at several oci in the 
nerve terminals. Aluminium exposure was seen to consid- 
erably alter the activity of the Ca 2+ effiuxing enzyme of 
the cell, Ca 2 * ATPase. Following both in vitro and in vivo 
A13* exposure, a decrease in the activity of this enzyme 
was observed. Evidence suggests that a similar kind of 
decrease in the enzyme activity in neuronal cells of pa- 
tients of Alzheimer's disease may be as a result of similar 
series of events in both the cases. Aluminium is known to 
displace Mg 2+ from ATP to form an AI-ATP complex 
which is a dead-end inhibitor of Ca 2+ ATPase [21]. How- 
ever, a decrease in the biological activity of CaM, as 
observed in Fig. 7, may also account for the decreased 
Ca 2+ ATPase activity, as CaM is a known activator of the 
enzyme. An altered CaM conformation on A13* exposure 
has also been reported by Seigal and Haug [22]. However, 
the possibility that A13* may be acting directly on the 
active site of the enzyme also cannot be ruled out. The 
reversal of inhibition of Ca 2+ ATPase by exogenously 
added DES, a known AI 3* chelator, further substantiates 
that AI 3+ might be responsible for impairing the activity 
of this enzyme, since chelation of  AI 3+ restores the activ- 
ity back to normal. The partial reversal in the presence of 
glutathione may be attributed to the sulfhydryl groups 
present in GSH, that prevent he interaction of A13* with 
Ca :+ ATPase. 
As evident from the data, there was a marked increase 
in the [Ca2+]i levels as a result of decreased Ca,-* effiux- 
ing ability of the cell following AI 3* administration. Fur- 
ther, the elevation in levels of [Ca,-+]i following AI 3* 
exposure might also be due to the release of Ca ,-+ from 
intracellular stores, a process reported to be triggered in 
the presence of metals [23]. Increased [Ca,- + ]i is a sensitive 
index of neurotoxic damage and is responsible for a wide 
variety of events, such as enhanced production of free 
radicals which potentiate lipid peroxidation [24]. The stim- 
ulation of lipid peroxidation by Ca 2* can be explained, 
based on their ability to liberate Fe 2+ bound with nega- 
tively charged groups of lipids, thereby increasing the 
concentration of catalytically active Fe ,-+ in the system, 
which augment free radical release and eventually per- 
oxidation of lipids. However, the possibility that the effect 
of AI 3* is probably due to a direct interaction with cellular 
components affecting the physical state of membranes 
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cannot be eliminated. Besides, raised levels of [Ca 2+ ]i are 
also responsible for increase in the spontaneous release of 
neurotransmitters, altered cytoskeletal organisation, im- 
paired action of hormones and growth factors, activation of 
proteases, lipases and endonucleases and impairment of 
mitochondrial oxidative phosphorylation, etc. [251. 
It was observed that concomitant to the increase in 
[Ca'-+ ]i, there was an accentuation i the levels of LPx. A 
major consequence of enhanced LPx is the oxidative dete- 
rioration of cellular membranes. In the present study it has 
been demonstrated that AI 3 + alters the neuronal membrane 
integrity in terms of increased fluorescence polarisation, 
with consequent decreased fluidity of membranes. Thus it 
can be suggested that peroxidation of membrane lipids 
might be responsible for rigidifying the membranes, a fact 
corroborated by Gutteridge and Halliwell [26] and may 
effect the functioning of membrane-bound enzymes, recep- 
tors and channels. 
We have observed an enhanced spontaneous release of 
neurotransmitters from nerve terminals following A13+ 
exposure [27], an observation justified by the increased 
[ Ca2 + ]i since neurotransmitter r lease has been reported to 
be linked with the levels of [Ca2+]~ [28], All Ca 2+ regu- 
lated neuronal functions like synaptic transmission, den- 
deltic induction, axonal transport and CaM-activated en- 
zymes would be affected by increased [Ca2+]i. Enhanced 
[ Ca2* ]i may have dramatic onsequences on the develop- 
ing brain, by decreasing neurite outgrowth, pruning den- 
drites and ultimately resulting in death of individual neu- 
rons. 
Voltage-operated calcium channels open transiently in 
response to depolarization, to regulate the entry of calcium 
through the neuronal membranes [29]. This influx of Ca 2+ 
then provides the stimulus for the release of neurotrans- 
mitters from the synaptic vesicles into the synaptic cleft. 
Aluminium was seen to have an inhibitory effect on both 
the depolarization and polarization dependent 45Ca2+ in- 
flux, in a concentration-dependent manner. The IC50 con- 
centration of AI 3+ for net K+-induced 45Ca2+ influx was 
50 /.tM, suggesting thereby that A13+ is capable of dis- 
placing Ca 2+ transport, in a manner consistent with the 
observation of Nachshen [30] who in a study on the effects 
of varying concentrations of Ca 2+ (0-2.5 mM) in the 
extracellular medium, reported A13~ to act as a partially 
competitive inhibitor, preventing Ca 2+ ions from reaching 
a binding site on or within the channel. However, the 
inhibitory effect is not solely competitive, but is rather 
better described to be of a mixed type. It can be proposed 
that in addition to a competitive interaction with the Ca ~-+ 
binding site, there are Al~+-induced perturbations, either in 
the structure of the channel molecule itself or in the 
phospholipid omain in close proximity to the channels as 
evident from the altered membrane fluidity of neuronal 
cells, demonstrated in the present study. Such a competi- 
tion between Ca 2+ and A13+ has been observed in intesti- 
nal absorption of Ca ~-~ and deposition in bone [31]. In vivo 
A13+ exposure was seen to decrease the fast phase of Ca 2. 
uptake by the VOCC, a fact supported by the observations 
of Koenig and Jope [1]. This observation suggests that 
Al3+-induced reduction in the capacity of the neurons to 
take up Ca 2+ could dramatically alter intraneuronal Ca 2~ 
homeostasis with resultant impaired neurotransmission. The 
decreased epolarization-dependent Ca 2+ uptake has also 
been reported in neuronal disorders and during the aging 
process [32,33]. Therefore, these results demonstrate that 
decreased Ca ~-+ uptake would significantly alter Ca 2- 
homeostasis with obvious detrimental consequences. 
Our study has demonstrated a decreased Ca ~- + extrusion 
capacity of the cell in terms of decreased Ca 2+ ATPase 
activity resulting in an enhanced [Ca2+] i and consequent 
altered neuronal function. Since altered concentrations of
Ca 2~ binding proteins have been reported in diseased 
states of CNS [34], therefore the effect of A13+ on Ca 2+ 
binding regulatory proteins was studied. Aluminium expo- 
sure was seen to alter the biological activity of CaM which 
may consequently have detrimental effects on the vital 
CaM-dependent processes, such as the regulation of disas- 
sembly of cellular cytoskeleton through inhibition of the 
polymerization of cytoskeletal proteins, neurotransmitter 
synthesis and release, metabolism of carbohydrates, lipids 
and amino acids and perhaps gene expression [35]. 
Protein kinase C is a Ca 2* phospholipid-dependent 
kinase. It is highly concentrated in the brain [36], localized 
in the presynaptic nerve terminal [37] and regulates neuro- 
transmitter elease in the mammalian CNS via a G 
protein-coupled mechanism [38]. Inhibition of PKC follow- 
ing AI 3* exposure, as observed in the present study, might 
induce perturbations in the phospholipid omains, conse- 
quently altering AI 3+ to modulate the intramembranal 
G-protein, which regulates Ca 2~ channel function and 
PKC activity. Thus learning and memory deficits might 
result from reduced neurotransmitter r lease due to AI 3+ 
induced inhibition of PKC, and Ca 2+ utilization at the 
presynaptic site. Moreover, our results demonstrate maxi- 
mum A1 ~+ accumulation i  the hippocampus (80-tbld), a 
region associated with the processes of memory and learn- 
ing, further substantiating the evidence that AI 3+ plays a 
role in the etiopathogenesis of Alzheimer's disease and 
other neurodegenerative disorders. 
The mechanisms responsible for the neurotoxic effects 
of AI 3+ are not very well understood. As AI 3+ is a 
multivalent cation with reported effects on membranes, 
membrane proteins and some Ca 2÷ binding proteins, the 
effect of A13÷ on synaptosomal Ca > homeostatic mecha- 
nisms was studied. Based on the present results, it can be 
implied reasonably, that A1 ~* can effectively alter Ca ~-+ 
homeostatic mechanisms by interfering with the 'steady 
state" Ca ~-+ homeostasis, following an inhibition of Ca 2. 
ATPase, thereby altering levels of resting [Ca 2+ ]. Alterna- 
tively, it could also interfere with transient fluxes through 
Ca 2+ channels in synaptic plasma membrane, thereby 
altering the excitability of neurons and eventually conduc- 
54 D. Julka, K.D, Gill / Biochimica et Biophysica Acta 1315 (1996) 47-54 
tion of action potential along the axons. The action of 
calcium receptor proteins CaM and PKC was also im- 
paired, thereby effecting neuronal functioning. 
Acknowledgements 
Financial assistance for carrying out this work was 
provided by the Postgraduate Institute of Medical Educa- 
tion and Research, Chandigarh- 160012, India. 
References 
[1] Koenig, M.L. and Jope, R.S. (1987) J. Neurochem. 49, 316-320. 
[2] Candy, J.M., Oakley, A.E. and Klinowski, J. (1986) Lancet ii, 
354-357. 
[3] Perl, D.P. and Brody, A.R. (1980) Science 208, 297-299. 
[4] Garruto, R.M., Fukastu, R., Yanagihara, R., Gajdusek, D.C., Hook, 
G. and Fiori, C.E. (1984) Proc. Natl. Acad. Sci. USA 81, 1875-1879. 
[5] Cheek, T.R. (1991) Curr. Opinion Cell Biol. 3, 199-205. 
[6] Lynch, G. and Baudry, M. (1984) Science 224, 1057-1063. 
[7] Glowinski, J. and Iversen. L.L. (1966) J. Neurochem. 13, 655-669. 
[8] Jones, D,H. and Matus, A.I. (1974) Biochim. Biophys. Acta 356, 
276-287. 
[9] Gray, E.G. and Whittaker, V.P. (1962) J. Anat. 96, 79-88. 
[10] Edelfors, S. and Ravn-Jonsen, A. (1991) Pharmacol. Toxicol. 69, 
90-95. 
[l 1] Desaiah, D., Chetty, C.S. and Prasada Rao, K.S. (1985) J. Toxicol. 
Environ. Health 16, 189-196. 
[12] Fiske, C.H. and SubbaRow, Y. (1925) J. Biol. Chem. 66, 375-400. 
[13] Adamson, P., Hajimohammadreza, I., Bremmer, M.J. and Campbel, 
I.C. (1989) Eur. J. Pharmacol. 162, 59-66. 
[14] Grynkiewicwz, G., Poenie, M. and Tsien, R,Y. (1985) J. Biol. 
Chem. 260, 3440-3450. 
[15] Wills, E.D. (1966) Biochem. J. 99, 667-676. 
[16] Shinitzky, M, and Inbar, M. (1976) Biochim. Biophys. Acta 433, 
133-149. 
[17] Wallace, R.W., Tallant, E.A. and Cheung, W.Y. (1983) Methods 
Enzymol. 102, 39-47, 
[18] Kikkawa, V., Go, M., Koumoto, J. and Nishizuka, Y. (1986) 
Biochem. Biophys. Res. Commun. 136, 636-643. 
[19] Zumkley, H., Bertram, H.P., Lison, A., Knoll, O. and Losse, H. 
(1979) Clin. Nephrol. 12, 18-21. 
[20] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) 
J. Biol. Chem. 193, 265-275. 
[21] Trapp, G.A. (1986) Kidney Int. 29, S-12-S-16. 
[22] Seigal, N. and Haug, A. (1983) Biochim. Biophys. Acta 744, 36-45. 
[23] Prabhu, S.D. and Salama, G. (1990) Arch. Biochem. Biophys. 277, 
47-55. 
[24] Babizhayev, M.A. (1988) Arch. Biochem. Biophys. 266, 445-451. 
[25] Choi, D,W. (1988) Neuron 1,623-624. 
[26] Gutteridge, J.M.C. and Halliwell, B. (1990) Trends Biochem. Sci. 
15, 129-135. 
[27] Julka, D., Sandhir, R. and Gill, K.D. (1995) J. Neurochem., in press. 
[28] Publicover, S.J. (1985) Comp. Biochem. Physiol. 82A, 7 - l l .  
[29] Tsien, R.W., Lipscombe D., Madison, D.V., Bley, K.R., Fox, A.P. 
(1988) Trends Neurosci. 1 l, 431-438. 
[30] Nachshen, D.A. (1984) J. Gen. Physiol. 83,941-967. 
[31] Goodman, W.G. (1986) Am. J. Kidney Dis. 6, 330-335. 
[32] Peterson, C. and Gibson, G.E. (1983) J. Biol. Chem. 258, 11482- 
11486. 
[33] Leslie, S.W, Chandler, L.J.,Barr, E., Farrar, R,P. (1985) Brain Res. 
329, 177-183. 
[34] Heizmann, C. and Hunziker, W. (1991) Trends Biochem. Sci. 16, 
98-103. 
[35] Hanson, P.I. and Schulman, H. (1992) Annu. Rev. Biochem. 61, 
559-601. 
[36] Kuo, J.F., Anderson, R.G.G., Wise, B.C. et al. (1980) Proc. Natl. 
Acad. Sci. USA 77, 7039-7043. 
[37] Girard, P.R., Mazzei, G.J. and Kuo, J.F. (1986) J. Biol, Chem. 261, 
370-375. 
[38] Worley, P.F., Baraban, J.M., Van Dop, C.V. and Snyder, S.H. 
(1986) Proc. Natl. Acad. ScL USA 83, 4561-4565. 
